Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Buy
26,030
+17,050
+190% +$795K 0.69% 19
2025
Q4
$435K Buy
8,980
+1,522
+20% +$75.4K 0.2% 145
2025
Q3
$352K Sell
7,458
-1,552
-17% -$74.9K 0.15% 219
2025
Q2
$435K Buy
+9,010
New +$460K 0.24% 129
2025
Q1
Sell
-4,180
Closed -$202K 1326
2024
Q4
$202K Buy
+4,180
New +$213K 0.2% 112

Other funds holding SNY

R Squared's SNY Position: Q1 2026 in Review

R Squared increased its Sanofi (SNY) stake by 190% in Q1 2026, buying an estimated $795K and bringing the position to 26,030 shares worth $1.25M. The position accounts for 0.69% of the portfolio, ranked #19.

R Squared first reported a position in SNY in Q4 2024 and has held it in 5 quarters since. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • R Squared held 26,030 shares of Sanofi worth $1.25M as of Q1 2026.
  • R Squared bought 17,050 Sanofi shares in Q1 2026, an estimated $795K.
  • Sanofi made up 0.69% of R Squared's portfolio in Q1 2026, its #19 holding.
  • R Squared first reported a position in Sanofi in Q4 2024 and has held it in 5 quarters since.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.